Mother-to-child transmission of HIV-1: timing and implications for prevention (Q36635880)

15 August 2017

1 reference

title

Mother-to-child transmission of HIV-1: timing and implications for prevention (English)

1 reference

15 August 2017

0 references

prevention of HIV/AIDS

0 references

4

Denise J Jamieson

1 reference

15 August 2017

Athena P Kourtis

1

0 references

Elaine J Abrams

series ordinal

3

object named as

Elaine J Abrams

1 reference

15 August 2017

5

Marc Bulterys

1 reference

15 August 2017

Francis K Lee

2

1 reference

PubMed ID

17067921

15 August 2017

language of work or name

1 reference

1 November 2006

1 reference

Lancet Infectious Diseases

15 August 2017

1 reference

15 August 2017

6

1 reference

15 August 2017

11

1 reference

15 August 2017

726-732

1 reference

Trends in human immunodeficiency virus (HIV) counseling, testing, and antiretroviral treatment of HIV-infected women and perinatal transmission in North Carolina

15 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Tracking the HIV epidemic: current issues, future challenges.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Understanding the timing of HIV transmission from mother to infant

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study G

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Prevention of perinatal HIV transmission: a review of novel strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Least microtransfusion from mother to fetus in elective cesarean delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

The risk of human immunodeficiency virus-1 infection in twin pairs born to infected mothers in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

15 Month follow up of African children following vaginal cleansing with benzalkonium chloride of their HIV infected mothers during late pregnancy and delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Vaginal lavage with chlorhexidine during labour to reduce mother-to-child HIV transmission: clinical trial in Mombasa, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Absence of maternal-fetal transmission of human immunodeficiency virus type 1 to second-trimester fetuses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

The Interface of Perinatal HIV Prevention, Antiretroviral Drug Resistance, and Antiretroviral Treatment: What Do We Really Know?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Transmission of HIV-1 through breastfeeding among women in Dar es Salaam, Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

HIV transmission through breastfeeding: a study in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Breast milk and HIV-1: vector of transmission or vehicle of protection?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Breast-milk infectivity in human immunodeficiency virus type 1-infected mothers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Breastmilk RNA viral load in HIV-infected South African women: effects of subclinical mastitis and infant feeding

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Breast-feeding and HIV-1 transmission in resource-limited settings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Correlation of virus load and soluble L-selectin, a marker of immune activation, in pediatric HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

Prevention of Mother‐to‐Child Transmission of HIV‐1 through Breast‐Feeding: Past, Present, and Future

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2806%2970629-6

7 January 2021

10.1016/S1473-3099(06)70629-6

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17067921